Powered by

News from the healthcare industry

  • Article - 12-Jan-2017

    Based on an accredited test method, the Fraunhofer IGB has developed an in vitro phototoxicity assay to measure the phototoxic potential of substances in medications and lotions used to protect the skin against environmental influences, which can become toxic when exposed to UV light. The assay uses human skin cells that have been grown into three-dimensional tissue as a human skin model.

  • Article - 09-Jan-2017

    A remedy is now available for people suffering from dry eye disease. Novaliq GmbH, a specialty pharmaceuticals company from Heidelberg, has developed a highly innovative technology platform for producing innovative drugs to eliminate common eye conditions that cause itching, burning and a feeling of pressure on the eye. The new drug delivery platform not only opens up groundbreaking new prospects for ophthalmology, but also for dermatology.

  • Press release - 05-Jan-2017

    Phenex Pharmaceuticals AG (Phenex) today announced that the company has received a 100 M USD milestone payment from Gilead Sciences, Inc. of Foster City, CA, U.S.A., for its program with GS-9674 targeting nonalcoholic steatohepatitis (NASH).

Dossier - 20.10.2016

The digitalisation of industry affects the entire value chain. From individual products to digitising workflows in companies and connecting companies with clients and service providers via the Internet of Things – Industry 4.0 makes completely new manufacturing processes possible and requires new and specific business models.

  • Funding

    Funding programme, Funded by: ERA-Net, Submission deadline: 13-Feb-2017
  • Funding

    Funding programme, Funded by: ERA-Net, Submission deadline: 01-Feb-2017
  • Funding

    Funding programme, Funded by: BMBF, Submission deadline: 09-Mar-2017

Upcoming events

Website address: https://www.gesundheitsindustrie-bw.de/en/